health
EU Project : CONCISE
CONCISE aims to generate a European-wide debate on science communication, involving a wide array of stakeholders, from media outlets to policy makers, from scientists to business companies, from science communicators to civil society organisations. CONCISE aims at providing qualitative knowledge through citizen consultation on the means/channels (media and social networks, life experience, relatives, religion, political ...
A scientist’s opinion : Interview with Prof. Donald Milton about SARS-CoV
We speak with Prof. Donald Milton, Professor of Environmental Health, Applied Environmental Health (MIAEH), about the differences between SARS-CoV-1 and SARS-CoV-2. Taking the precautionary principle in medicine into consideration, in your opinion why does the WHO insist on its statement regarding the transmission competence of SARS-CoV-2? Do you envisage a different (international) governmental approach soon? ...
A scientist’s opinion : Interview with Dr. Marc Wathelet about SARS-CoV
We speak with Dr. Marc Wathelet, Molecular Biologist, Coronavirus specialist, about the differences between SARS-CoV-1 and SARS-CoV-2 Taking your early, alarming statements and the precautionary principle in medicine into consideration, in your opinion why does the WHO insist on its statement on the transmission competence of SARS-CoV-2? Do you envisage a different (international) governmental approach ...
Vaccine perspectives for COVID-19 – Interview with Prof. Rino Rappuoli & Prof. Sarah Gilbert
Covid-19 urges policy makers and the big pharma to fasten vaccine developments and possible treatments for the novel coronavirus, SARS-CoV-2. Will the vaccine be specific to Covid-19 only, or will it be suitable for all SARS coronaviruses? Will it be suitable to all ages? What are the greatest challenges of vaccine production processes and why does it take so long?
Ilaria Capua: A preparedness plan against unknown viruses is crucial for Europe
Interview on COVID-19 with Ilaria Capua, DVM, PhD, Director of the One Health Center of Excellence for Research and Training, University of Florida, USA. There are tests for COVID-19 which detects the virus, other which detects antibodies. Could you briefly describe the differences of these two tests? The rapid spread of the outbreak required rapid ...
Helena Legido-Quigley: “Austerity saps the ability of a health system to respond to COVID-19”
Interview on COVID-19 with Helena Legido-Quigley, Associate Professor of Global Health at the London School of Hygiene and Tropical Medicine and at the National University of Singapore. What role has Spain played in the COVID-19 pandemic? Helena Legido-Quigley: Spain has been slow, but as equally slow as the rest of Europe. The continent lost a ...
EU Project : EU-ToxRisk
EU-ToxRisk is an Integrated European ‘Flagship’ Programme Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st century. The vision of this project is to drive the required paradigm shift in toxicological testing away from ‘black box’ animal testing towards a toxicological assessment based on human cell responses and a comprehensive mechanistic understanding of cause-consequence ...
Alternative approaches to animal testing
In 1959, The Principles of Humane Experimental Technique was published by Russell and Burch, introducing the 3Rs concept (replacement, reduction, and refinement) regarding animal use in the scientific community. Just over 60 years later, it is timely to review progress to date and the future outlook regarding alternative approaches to animal testing.